Porton Advanced recently introduced the
This equipment, known for its exceptional high transfection efficiency and cell viability, is capable of handling flexible transfection volumes and covering the entire process from research to clinical stages and cGMP production. It also seamlessly scales up for large-volume preparations.
Porton Advanced is equipped with comprehensive cell therapy process equipment that can meet the production needs of various cell types, including cell banking and autologous or allogeneic cell therapy production, while supporting multiple process routes such as viral vector transfection, non-viral vector electroporation, and gene editing, etc. By introducing the
For the process development and clinical production involved in electroporation technologies of different cell therapies, Porton Advanced will collaborate with
About Porton Advanced
Porton Advanced is a subsidiary of the globally recognized
Porton Advanced operates on a 'Customer First' approach to Gene and Cell Therapeutics (GCT) manufacturing, anchored by its core principles of 'Compliance, Expertise, and Open Collaboration'. The company operates to rigorous, internationally harmonized Quality Management and IP protection standards, bringing innovative manufacturing solutions to the complex challenges in the GCT space.
Contact:
Tel: +1 (908)-565-4183
Email: info@portonadvanced.com
(C) 2024 Electronic News Publishing, source